Together they aim to cover fat metabolism, systemic signaling, and direct tissue repair
Combining these two can compound GI distress, making it harder to distinguish which agent is responsible and potentially reducing tolerability and compliance
It is particularly suited for sensitive bioactive compounds like enzymes and antigens
41 Smith, Phase II Metabolism, UNC Chapel Hill, 8/2012 UGT PolymorphismTo date, deficient conjugation with bilirubin which leads to severe disease (Crigler Najar) or elevated bilirubin (Gilberts syndrome) have been identified
Variants in GIPR, MC4R, and FTO can influence peptide response potential, though they do not determine outcomes
Kannt, A., et al